Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Avonex
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Avonex 30microgram inj vials
0802040M0BDAAAE
|
Avonex | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Avonex 30micrograms/0.5ml (6million units) inj pf pens
0802040M0BDACAM
|
Avonex | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Avonex 30micrograms/0.5ml (6million units) inj pfs
0802040M0BDABAF
|
Avonex | Interferon beta | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.